News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,678 Results
Type
Article (40121)
Company Profile (271)
Press Release (662286)
Multimedia
Podcasts (54)
Webinars (12)
Section
Business (205110)
Career Advice (2021)
Deals (35534)
Drug Delivery (97)
Drug Development (81245)
Employer Resources (172)
FDA (16219)
Job Trends (14920)
News (346495)
Policy (32654)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49789)
ALS (93)
Alzheimer's disease (1388)
Antibody-drug conjugate (ADC) (135)
Approvals (16216)
Artificial intelligence (262)
Autoimmune disease (23)
Automation (16)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (190)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (291)
Cancer (2314)
Cardiovascular disease (179)
Career advice (1689)
Career pathing (30)
CAR-T (156)
Cell therapy (439)
Cervical cancer (20)
Clinical research (66194)
Collaboration (863)
Company closure (2)
Compensation (557)
Complete response letters (19)
COVID-19 (2606)
CRISPR (42)
C-suite (252)
Cystic fibrosis (101)
Data (2299)
Decentralized trials (2)
Denatured (21)
Depression (44)
Diabetes (276)
Diagnostics (6399)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (104)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87111)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (113124)
Executive appointments (744)
FDA (17585)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (770)
Gene editing (111)
Generative AI (19)
Gene therapy (309)
GLP-1 (720)
Government (4441)
Grass and pollen (4)
Guidances (150)
Healthcare (18838)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (125)
Indications (29)
Infectious disease (2752)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (97)
Interviews (312)
IPO (16555)
IRA (42)
Job creations (3668)
Job search strategy (1434)
Kidney cancer (10)
Labor market (43)
Layoffs (482)
Leadership (17)
Legal (7945)
Liver cancer (76)
Lung cancer (324)
Lymphoma (156)
Machine learning (9)
Management (58)
Manufacturing (324)
MASH (73)
Medical device (13393)
Medtech (13398)
Mergers & acquisitions (19546)
Metabolic disorders (704)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1938)
NextGen: Class of 2025 (6548)
Non-profit (4491)
Now hiring (40)
Obesity (371)
Opinion (208)
Ovarian cancer (80)
Pain (92)
Pancreatic cancer (89)
Parkinson's disease (150)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (46)
People (57671)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20638)
Phase II (29165)
Phase III (21701)
Pipeline (1344)
Policy (149)
Postmarket research (2564)
Preclinical (8789)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (382)
Real estate (5953)
Recruiting (65)
Regulatory (22389)
Reports (47)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (134)
Series B (87)
Service/supplier (13)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3632)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (31)
Vaccines (700)
Venture capitalists (44)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Last 7 days (936)
Last 30 days (3006)
Last 365 days (32475)
2025 (11714)
2024 (35330)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38085)
Australia (6238)
California (6392)
Canada (2060)
China (533)
Colorado (273)
Connecticut (278)
Delaware (156)
Europe (81885)
Florida (946)
Georgia (212)
Idaho (58)
Illinois (548)
India (26)
Indiana (319)
Iowa (11)
Japan (171)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (919)
Massachusetts (4744)
Michigan (223)
Minnesota (401)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (64)
New Jersey (1784)
New Mexico (28)
New York (1795)
North Carolina (986)
North Dakota (8)
Northern California (2809)
Ohio (210)
Oklahoma (14)
Oregon (35)
Pennsylvania (1419)
Puerto Rico (13)
Rhode Island (33)
South America (1100)
South Carolina (25)
South Dakota (1)
Southern California (2409)
Tennessee (105)
Texas (950)
United States (23926)
Utah (188)
Virginia (152)
Washington D.C. (65)
Washington State (565)
West Virginia (3)
Wisconsin (56)
702,678 Results for "neurocrine biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurocrine Biosciences to Present at Upcoming Investor Conferences in May 2025
May 7, 2025
·
1 min read
Press Releases
Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance
May 5, 2025
·
16 min read
Press Releases
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
April 4, 2025
·
6 min read
Press Releases
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2025 Financial Results
April 14, 2025
·
1 min read
Press Releases
Neurocrine Biosciences Initiates Phase 3 Registrational Program for NBI-1117568 as Potential Treatment for Adults with Schizophrenia
April 30, 2025
·
7 min read
Press Releases
Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum
March 12, 2025
·
1 min read
Press Releases
Neurocrine Biosciences to Present at Upcoming Investor Conferences in March
February 25, 2025
·
1 min read
Press Releases
Neurocrine Biosciences Announces New Survey Revealing Need for Routine Screening and Earlier Diagnosis for People Living with Tardive Dyskinesia
May 5, 2025
·
11 min read
Press Releases
Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia
May 1, 2025
·
7 min read
Biotech Beach
Neurocrine Biosciences to Participate at Investor Conferences in June 2024
Neurocrine Biosciences, Inc. will participate at two upcoming investor conferences in June.
May 29, 2024
·
2 min read
1 of 70,268
Next
